ADVFN - Advanced Financial Network.
HOME» NYSE » P » PKI Stock Price » PKI Stock News

Perkin Elmer Share News

 Perkinelmer, Inc. Stock Price
PKI Stock Price
 Perkinelmer, Inc. Stock Chart
PKI Stock Chart
 Perkinelmer, Inc. Stock News
PKI Stock News
 Perkinelmer, Inc. Company Information
PKI Company Information
 Perkinelmer, Inc. Stock Trades
PKI Stock Trades

PerkinElmer Isn't For Sale, CEO Says; Shares Slide

By Caitlin Nish Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- PerkinElmer Inc. (PKI) isn't for sale, its chief executive said Friday, disputing reports that sent its stock up 6.9% Thursday. "Media reports containing speculation to the effect that PerkinElmer is for sale, or positioning itself for sale, are inaccurate," CEO Robert Friel said in a statement. "A sale of the company is not being discussed, and such a transaction is not in the company's strategic plans." Shares of PerkinElmer, which sells analytical products and services to the health-care and industrial sectors, slid 3.6% in recent trading to $26.72. They are up 19% in the past year. Friel was responding to reports Thursday suggesting the company was considering pursuing a large acquisition or putting itself up for sale after making an unsuccessful attempt for medical-test maker Beckman Coulter Inc. (BEC). Danaher Corp. (DHR) earlier this month agreed to acquire Beckman Coulter for $5.87 billion, ending two months of speculation about the future of Beckman, which endured a rough year last year following the recall of a faulty test for heart problems, multiple financial-guidance cuts and an unexpected CEO resignation. "We continue to be on strategy with regard to our plans for growth, and we remain in strong financial health," Friel said. "PerkinElmer remains committed to growing our business and leveraging the strong foundation we've already built to achieve future growth," he added. PerkinElmer reported at the beginning of this month that its fourth-quarter earnings soared as it booked a $315.3 million gain on the disposition of discontinued operations. It saw growth in both its environmental-health division and human-health division, with revenue up 8% and 12%, respectively. -By Caitlin Nish, Dow Jones Newswires; 212-416-2076; --Jon Kamp and Lauren Pollock contributed to this article.

Stock News for Perkin Elmer (PKI)
08/01/201416:49:34MARKET SNAPSHOT: S&P 500 Suffers Largest Weekly Loss In 2 Years
08/01/201416:27:34MARKET SNAPSHOT: Dow Falls Friday, Suffers Largest Weekly Loss...
08/01/201415:28:50MARKET SNAPSHOT: Dow Falls Further, Faces Largest Weekly Loss...
08/01/201413:46:21MARKET SNAPSHOT: U.S. Stocks Drop Sharply On Rate-hike Fears
11/15/201308:55:37Highbridge Capital Management 3Q 13F: Largest Eliminations
11/15/201308:55:35Highbridge Capital Management 3Q 13F: Largest Purchases
11/15/201308:55:35Highbridge Capital Management 3Q 13F: Largest Sales
11/15/201308:55:35Highbridge Capital Management 3Q 13F: Largest -2-
04/26/201316:43:52MARKET SNAPSHOT: U.S. Stocks End Lower; H-P, Chevron Boost Dow
04/26/201315:47:11MARKET SNAPSHOT: S&P 500 Nearly Erases Losses As Apple Gains
04/26/201314:31:37MARKET SNAPSHOT: U.S. Stocks Fall After GDP Report; H-P Boosts...
04/26/201313:40:11MARKET SNAPSHOT: U.S. Stocks Fall After GDP Data; H-P Boosts...
04/26/201307:10:10U.S. Stock Futures Fall Before GDP
04/21/201200:20:37MARKET SNAPSHOT: U.S. Stock Gains Hinge On Apple, Blue-chip Results
10/07/201115:01:13Illumina Problems Cast Shadow Over Biotech Sector
08/04/201117:13:19PerkinElmer 2Q Profit Down 50% On Expenses; Raises Outlook
03/24/201109:56:01PerkinElmer Boosts Software Offerings In 2 Deals Valued At $220...
02/25/201112:38:49PerkinElmer Isn't For Sale, CEO Says; Shares Slide

Perkin Elmer and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations